Abstract:
The present invention provides a cosmetic or food composition which is excellent in a skincare effect, particularly an effect of whitening the skin browned due to ultraviolet radiation or aging, and which can be safely used for many mammals. The present invention provides a whitening composition comprising reduced coenzyme Q represented by formula (1) as an effective component: wherein n represents an integer of 1 to 12. The present invention also provides a whitening composition further comprising oxidized coenzyme Q represented by formula (2) as an effective component: wherein n represents an integer of 1 to 12. The present invention also provides a method for whitening the skin of a mammal, the method comprising administering the mammal with the composition.
Abstract:
A method of efficiently producing reduced coenzyme Q 10 having excellent qualities which is useful in foods, foods with nutrient function claims, foods for specific health uses, nutritional supplements, tonics, animal drugs, drinks, feeds, cosmetics, drugs, remedies, preventives and so on. This method is suitable for industrial production thereof. Namely, reduced coenzyme Q 10 can be handled in a state of being protected from oxidation due to molecular oxygen by bringing the coenzyme Q 10 into contact with a solvent containing a strong acid. By crystallizing in the presence of a strong acid, moreover, coenzyme Q 10 can be converted into crystals while minimizing the formation of the oxidized coenzyme Q 10 as a by−product, thereby giving reduced coenzyme Q 10 having excellent qualities.
Abstract:
With respect to reduced coenzyme Q10, there has been no report about the presence of crystal polymorphism, and it has been considered that a conventionally obtained crystal form is only one form. The present invention relates to a reduced coenzyme Q10 crystal having an endothermic peak indicating melting at 54 ~ 2°C during temperature rise at a rate of 5°C/min by differential scanning calorimetry (DSC), and/or to a reduced coenzyme Q10 crystal showing characteristic peaks at diffraction angles (2.theta. ~ 0.2°) of 11.5°, 18.2°, 19.3°, 22.3°, 23.0° and 33.3° by powder X-ray (Cu-K.alpha.) diffraction. The crystal form is a novel reduced coenzyme Q10 crystal which has a higher melting point and a lower solubility in a solvent, and is more excellent in stability than the conventionally known reduced coenzyme Q10 crystal.
Abstract:
Método de purificación de coenzima Q10 reducida que puede obtenerse por reducción de coenzima Q10 oxidada, en el que se eliminan impurezas solubles en agua de la coenzima Q10 reducida, en el que el lavado de los cristales y/o el aceite de la coenzima Q10 reducida comprende poner en contacto cristales y/o aceite de la coenzima Q10 reducida con un disolvente orgánico soluble en agua o un disolvente mixto compuesto de un disolvente orgánico soluble en agua y agua en un recipiente y en el que el lavado de los cristales y/o el aceite de la coenzima Q10 reducida se lleva a cabo en un estado de dispersión de los cristales y/o el aceite de la coenzima Q10 reducida en el disolvente orgánico soluble en agua o el disolvente mixto compuesto del disolvente orgánico soluble en agua y agua y en el que los cristales y/o el aceite de la coenzima Q10 reducida se selecciona(n) del grupo que consiste en: cristales obtenibles mediante cristalización de o concentración hasta sequedad de una disolución que contiene coenzima Q10 reducida; un sólido que resulta de la solidificación de aceite de coenzima Q10 reducida; un aceite que resulta de la fusión de cristales de coenzima Q10 reducida; y un aceite obtenible concentrando una disolución que contiene coenzima Q10 reducida a una temperatura no inferior a la temperatura de fusión.
Abstract:
The present invention provides a particulate composition wherein an oil component containing reduced coenzyme Q10 is polydispersed forming a domain in a matrix containing a water-soluble excipient, which simultaneously shows high oxidative stability and high oral absorbability, a production method thereof, and a stabilizing method thereof. It also provides a food, food with nutrient function claims, food for specified health uses, dietary supplement, nutritional product, animal drug, drink, feed, pet food, cosmetic, pharmaceutical product, therapeutic drug, prophylactic drug and the like, which contain the composition.
Abstract:
Disclosed are a method and a composition for stabilizing a reduced coenzyme Q which is useful as a food, a food with a nutrient function, a food for specified health uses, a nutritional supplement, a nutritional product, a veterinary drug, a beverage, a feeding stuff, a cosmetic, a pharmaceutical product, a therapeutic agent, a prophylactic agent and the like. The method is characterized by allowing a reduced coenzyme Q to coexist with a reduced coenzyme Q and/or a reduced coenzyme Q. The composition comprises a reduced coenzyme Q and a reduced coenzyme Q and/or a reduced coenzyme Q.
Abstract:
The present invention relates to a method for stabilizing reduced coenzyme Q10, which is useful as an ingredient in good foods, functional nutritive foods, specific health foods, nutritional supplements, nutrients, animal drugs, drinks, feeds, cosmetics, medicines, remedies, preventive drugs, etc., and to a composition therefor. The composition comprises reduced coenzyme Q10, a fat and oil (excluding olive oil) and/or a polyol, and doesn't substantially inhibit the stabilization of reduced coenzyme Q10. Additionally, the composition is a reduced coenzyme Q10-containing composition which comprises reduced coenzyme Q10, a polyglycerol fatty acid ester, and a fat and oil and/or a polyol.
Abstract:
Reduced coenzyme Q 10 is useful as functional nutritive foods, specific health foods and the like. The present invention provides a method for efficiently obtaining reduced coenzyme Q 10 of high quality and by a method suitable for a commercial production. It is possible to handle and stably preserve reduced coenzyme Q 10 under a condition that oxidation by a molecular oxygen is inhibited by contacting reduced coenzyme Q 10 with an ascorbic acid and citric acid or a related compound thereof, and thus a stabilized composition is obtained. Moreover, reduced coenzyme Q 10 is converted into a crystalline state in such a condition that the formation of oxidized coenzyme Q 10 as a byproduct is minimized by crystallizing reduced coenzyme Q 10 in the presence of ascorbic acid or a related compound thereof, etc., and thus a reduced coenzyme Q 10 crystal of high quality is produced. Furthermore, by successively crystallizing the generated reduced coenzyme Q 10 in the presence of ascorbic acid or a related compound thereof after reducing oxidized coenzyme Q 10 to reduced coenzyme Q 10 using ascorbic acid or a related compound thereof, operations are simplified and minimized, and thus reduced coenzyme Q 10 of high quality is produced.